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Abstract
Background:  The TGFβ1-induced signal transduction processes involved in growth and
differentiation are only partly known. The three-dimensional epithelial differentiation model, in
which T84 epithelial cells are induced to differentiate either with TGFβ1 or IMR-90 mesenchymal
cell-secreted soluble factors, is previously shown to model epithelial cell differentiation seen in
intestine. That model has not been used for large scale gene expression studies, such as microarray
method. Therefore the gene expression changes were studied in undifferentiated and differentiated
three-dimensional T84 cultures with cDNA microarray method in order to study the molecular
changes and find new players in epithelial cell differentiation.
Results: The expression of 372 genes out of 5188 arrayed sequences was significantly altered, and
47 of them were altered by both mediators. The data were validated and the altered genes are
presented in ontology classes. For the genes tested the expressions in protein level were in
accordance with the mRNA results. We also found 194 genes with no known function to be
potentially important in epithelial cell differentiation. The mRNA expression changes induced by
TGFβ1 were bigger than changes induced by soluble factors secreted by IMR-90 mesenchymal cells.
The gene expression data was depicted in already known signaling pathway routes.
Conclusion: Our results reveal potential new signaling pathways and several new genes affected
by TGFβ in epithelial cell differentiation. The differentiation induced by TGFβ1 appears to be more
potent than the differentiation induced by mesenchymal cells. This study indicates that our cell
culture model is a suitable tool in studying regulatory mechanisms during epithelial cell
differentiation in intestine. Furthermore the present results indicate that our model is a good tool
for finding new players acting in the differentiation of epithelial cells.
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Background
The intestinal epithelium comprises multiple cell types
which are progenitors of the stem cells located in crypt
region. During their migration along the crypt axis epithe-
lial cells differentiate from proliferative cells into secretory
cells or absorptive enterocytes [1] Epithelial cell growth,
motility and morphogenesis are controlled by soluble fac-
tors such as transforming growth factor beta (TGFβ) [1], a
multifunctional growth factor [2-4]. Mesenchymal cells
producing TGFβ are in turn regulated by various hormo-
nal, paracrine and exogenous factors [5,6]. Epithelial cells
can also regulate their own gene expression via negative
regulatory feedback loops [7]. The role of the specific sig-
naling pathways across the crypt axis, and the transcrip-
tion factors controlling the crypt-specific expression of
specific genes has been characterized [1], but the molecu-
lar events synergistically leading to the transition of crypt-
like cells into absorptive enterocytes call for further study.
The key to an understanding of cellular differentiation
and development is elucidation of the molecular events
regulating transcription. Research on epithelial cell differ-
entiation in primary cell cultures has been hampered by
the poor viability of stem cells [8], and the tumor cell lines
capable of differentiating have thus been extensively used
in studies of epithelial cell differentiation [8-11]. In a
model created by our group, T84 epithelial cells grown
three-dimensionally are induced to differentiate either by
soluble factors secreted by mesenchymal cells (IMR-90
fibroblasts) or by addition of TGFβ1 [12,13]. T84 cells dif-
ferentiated in this model are shown to express alkaline
phosphatase and sialomucin, that are usually expressed
by villus tip epithelial cells in normal duodenum, while
the expression of c-met-proto oncogene has been shown
to be down-regulated [12]. Differentiated T84 are shown
to be negative for sulfomucin that is usually expressed in
colon [12]. IMR fibroblast-induced differentiation of T84
cells has been shown to occur in a TGFβ1-dependent
manner [12]. The advantage of our model is that differen-
tiation commences only after induction, and the differen-
tiation process can therefore be studied precisely. It has
already been harnessed to study alterations in gene
expression during epithelial cell differentiation by
employing differential display [14-17]. By this method we
have found several novel candidate genes, for example
SAP30L, which might have a role in the epithelial cell dif-
ferentiation [15].
TGFβ1-induced cell-type specific signal transduction net-
works warrants further clarification [2]. In the present
study, using cDNA microarray and taking advantage of
our three-dimensional epithelial cell culture, our aim was
to find novel molecular changes in gene expression
accompanying epithelial cell differentiation only in
undifferentiated and differentiated cultures. Furthermore,
we compared the gene expressions in epithelial cells
mediated either by TGFβ1 or soluble factors excreted by
IMR-90 mesenchymal cells.
Results
In the three-dimensional epithelial cell differentiation
model, crypt-like T84 epithelial cells were induced to dif-
ferentiate either by TGFβ1 (hereafter called as TGFβ1-dif-
ferentiated) or by soluble factors secreted by IMR-90 type
human embryonic lung fibroblasts (hereafter called as
IMR-differentiated). The T84 cells cultured within colla-
gen gel supplemented with medium were used as undif-
ferentiated controls [12,13]. The study focused on
detecting changes in gene expression upon differentia-
tion; we therefore studied undifferentiated and differenti-
ated epithelial cells harvested after seven days of culturing.
Altogether the transcription of 372 out of 5188 genes was
found to be significantly altered when TGFβ1-differenti-
ated and IMR-differentiated cultures were compared to
the undifferentiated control culture. All the affected genes
were grouped into ontology classes according to their
known or predicted functions. From all significantly
altered genes 8.6% attended on metabolism, other than
energy metabolism (GO:0044237), and 90% of them
were down-regulated. Genes in the subgroup of metabo-
lism, the generation of precursor metabolites and energy
(GO:0006091), were affected in 2% of all genes. 5.6% of
genes controlled the cell cycle and DNA processing
(nucleic acid binding (GO:0003676)), and 91% of them
were down-regulated in differentiated cells. 17.5% of
affected genes regulated transcription regulator activity
(GO:0030528), and 83% of them were down-regulated in
differentiated cells. Genes coding proteins for signal trans-
ducer activity (GO:0004871, GO:0007165, GO:0007154)
was the largest functional group, 27% of all significantly
altered genes. 13% of the genes that had significantly
altered expression affected to protein folding i.e. cellular
macromolecule metabolism (GO:0044260). Genes hav-
ing a role to cell rescue and defense i.e. inflammatory
response (GO:0006954) were 5% of all affected genes. All
genes belonging to this group were down-regulated in dif-
ferentiated cells. Equal amount of affected genes (6%)
controlled cellular organization i.e. organelle organiza-
tion and biogenesis (GO:0006996I) and transport
(GO:0006810). One quarter (25%) of all affected genes
had yet no known role in biological processes
(GO:0000004). In IMR-differentiated cells several of the
genes were slightly but insignificantly affected (the expres-
sion ratios were between 0.8 and 1.25). A full list of the
genes in question is presented as an additional file (see
Additional file 5).
Gene ontology classes
We focused on genes which have been shown to function
in transcription regulation, or signal transduction, or
whose function remains unknown but putatively impor-BMC Genomics 2006, 7:279 http://www.biomedcentral.com/1471-2164/7/279
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tant in epithelial cell differentiation. The list of selected
genes is presented in Table 1. Six of the affected genes are
involved in the biosynthesis of cholesterol, and all of
them were down-regulated (Table 1, ontology class A).
Also genes associated with oxidative phosphorylation
were decreased (Table 1, B), as well as those controlling
the cell cycle and DNA processing (Table 1, C). CDK6 was
the only selected gene in this class up-regulated in TGFβ1-
differentiated but down-regulated in IMR-differentiated
epithelial cells. In the group of genes controlling tran-
scription and translation there were five zinc finger genes,
all down-regulated (Table 1, D). The genes with a role in
TGFβ-, the tyrosine kinase- and the wnt-signaling path-
ways, listed in the ontology class E, were all down-regu-
lated, as were those regulating protein folding, for
example cathepsin S and transglutaminase 2 (Table 1,
ontology class F). Genes which evinced significantly
altered expression and affected to cell rescue and defense
(G), cellular organization (H) and transport (I) are pre-
sented only in the supplementary data. Of the 372 genes
whose expression was changed, 94 (25%) had no func-
tion known so far. Some unknown genes potentially
important in epithelial cell differentiation are listed in
Table 1 as ontology class J.
Forty-seven out of the 372 affected genes were altered in
both TGFβ1- and IMR-differentiated epithelial cells as
compared to controls (Table 2); in 39 (85%) of them the
expression changes were to same direction. Differentia-
tion altered the expression of genes in all ontology groups.
Altogether 14 affected genes had a role in cell communi-
cation and signal transduction (Table 2, ontology class E)
and six genes affected in both sample groups had as yet no
known function (Table 2, J).
Validation of the array data
The genes arrayed twice on the filter acted as internal con-
trol points validating the data. The fourteen genes spotted
twice on the filter acted as internal control points validat-
ing the data. Correlation between the two expression
ratios of these genes was good (Pearson correlation coeffi-
cient r = 0.673, p = 0.0084), Table 3. Further validation of
the data was made with quantitative reverse transcription
PCR (RT-PCR) for genes that were selected from different
functional classes and from different expression levels
from the pool of 372 affected genes (supplementary data
list). The expression changes in vaccinia-related kinase 2
(VRK2), ganglioside activator protein (GM2A), crystallin
αB (CRYAB), dentatorubral-pallidoluysian atrophy
(DRPLA), deiodinase iodothyronine type II (DIO2), pro-
teasome subunit beta type 6 (PSMB), ATP-dependent
RNA helicase (ROK1), phospholipase C gamma 1
(PLCG1) and cytokeratin 19 (KRT19) were in concord-
ance with the microarray data, Correlation coefficient
between microarray and qRT-PCR results with linear Pear-
son's correlation was fairly good: r = 0.636, p = 0.0046,
Table 4.
Protein concentrations and immunohistochemistry
The Western immunoblotting was carried out with five
selected proteins to ascertain whether the changes seen at
mRNA level would be in concordance with the protein
level. Epidermal growth factor receptor (EGFR) and β-cat-
enin were chosen because they are involved in cell differ-
entiation and we detected changes in their expression at
mRNA level. C-myc, a nuclear phospho-protein and onco-
gene which regulates proliferation in cells was chosen as it
has been shown to be up-regulated in proliferating cells
[8]. Cytokeratin 19, a protein constructing intermediary
filaments, was also chosen because it was highly expressed
in differentiated cells [8]. β-actin was used as internal con-
trol [18]. The protein expression ratios of β-catenin, EGFR,
c-myc and cytokeratin 19 quantitated and calculated from
the Western blots (Fig. 1B), were comparable in TGFβ1-
differentiated and in IMR-differentiated cells (Fig. 1A).
The amount and localization of two selected proteins, c-
myc and cytokeratin 19, were further studied with immu-
nostainings. C-myc stained the nuclei intensively in
undifferentiated, unorganized T84 epithelial cell clusters
(Fig. 2A), whereas in TGFβ-treated, differentiated and
organized cell clusters the nuclei labeling was faint (Fig.
2B). In Figures 2C and 2D are the immunostainings with
cytokeratin 19. The labeling was clearly up-regulated
upon differentiation by TGFβ (Fig. 2D). The immunos-
tainings were in line with the results from microarray and
immunoblotting indicating high c-myc and low cytokera-
tin 19 concentrations in the undifferentiated control cul-
ture and low c-myc and high cytokeratin 19
concentrations in TGFβ-differentiated cell culture.
Discussion
The three-dimensional intestinal epithelial cell differenti-
ation model has been successfully used to study cell differ-
entiation [12-17,19]. In this model crypt-like T84 cells,
when grown three-dimensionally in collagen gel, are
induced to differentiate either by the soluble factors
secreted from IMR fibroblasts or by TGFβ1 [12,13]. IMR-
induced differentiation has been shown to occur in a
TGFβ-dependent manner [12], and it has been concluded
that the differentiation of T84 cells in the present co-cul-
ture models the differentiation of epithelial cells in intes-
tine [12,13,19].
Here we used the cDNA microarray method and our cell
culture model to gain additional insight into the genetic
programming of epithelial cells upon differentiation. Fur-
thermore, we examined similarities and differences in
gene expressions when differentiation was induced either
by TGFβ1 or by mesenchymal cell (IMR-90 fibroblast) sol-B
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Table 1: List of affected genes that had a significant change in their mRNA expression when TGFβ-differentiated T84 cells were compared to T84 cells grown solely in collagen I gel 
(= TGFβ-treated vs. control) and T84 cells differentiated by soluble factors secreted by mesenchymal cells were compared to T84 cells grown solely in collagen I gel 
(= IMR treated vs. control).
Gene ontology 
class
Gene name GenBank no chromosomal 
location
TGFβ-treated vs. control IMR-treated vs. control
ratio SD p-value FDR ratio SD p-value FDR
A DHCR24: 24-dehydrocholesterol reductase AA482324 1p33-p31.1 0.68↓ (±0.20) 0.699 0.733 1.01 (±0.14) 0.969 1.000
A FDPS: farnesyl diphosphate synthase (farnesyl 
pyrophosphate synthetase, 
dimethylallyltranstransferase, 
geranyltranstransferase)
T66907
T65907
1q22 0.29↓
0.57↓
(±0.24)
(±0.45)
0.180
0.148
0.291
0.272
1.43
1.06
(±1.32)
(±1.02)
0.807
0.499
1.000
1.000
A CYP1B1: cytochrome P450, family 1, subfamily B, 
polypeptide 1
AA448157 2p21 0.66↓ (±0.26) 0.724 0.795 0.68↓ (±0.23) 0.716 1.000
A CYP3A4: cytochrome P450, subfamily IIIA 
(niphedipine oxidase), polypeptide 4
R91078 7q21.1 0.70↓ (±0.05) 0.372 0.479 0.88 (±0.18) 0.520 1.000
A CYP2E: cytochrome P450, subfamily IIE (ethanol-
inducible)
H50500 10q24.3-qter 0.58↓ (±0.31) 0.509 0.607 0.96 (±0.60) 0.991 1.000
A CYP19A1: cytochrome P450, family 19, subfamily 
A, polypeptide 1
R32428 15q21.1 0.75↓ (±0.08) 0.744 0.812 1.09 (±0.14) 0.923 1.000
B SDHB: succinate dehydrogenase complex, subunit 
B, iron sulfur (Ip)
AA463565 1p36.1-p35 0.43↓ (±0.20) 0.041 0.265 0.81 (±0.38) 0.570 1.000
B UQCR: ubiquinol-cytochrome c reductase (6.4 kD) 
subunit
R46837 19p13.3 0.42↓ (±0.40 0.123 0.265 0.90 (±0.49) 0.629 1.000
C CDK6: cyclin-dependent kinase 6 H73724 7q21-q22 2.57↑ (±1.34) 0.418 0.525 0.61↓ (±0.34) 0.442 1.000
D EIF4E2: eukaryotic translation initiation factor 4E 
member 2
W01534 2q37 3.54↑ (±1.90) 0.390 0.495 0.90 (±0.71) 0.499 1.000
D TFDP2: transcription factor Dp-2 AA465444 3q23 0.57↓ (±0.18) 0.036 0.265 0.97 (±0.33) 0.920 1.000
D HNRPH1: heterogeneous nuclear 
ribonucleoprotein H1
W96114 5q35.3 0.53↓ (±0.24) 0.572 0.665 0.98 (±0.39) 0.739 1.000
D ZNF193: zinc finger protein 193 AA252169 6p21.3 0.49 (±0.20) 0.102 0.265 0.96 (±0.68) 0.482 1.000B
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D MYC: v-myc myelocytomatosis viral oncogene 
homolog (avian)
AA464600 8q24.12-q24.13 0.78 (±0.42) 0.156 0.275 0.91 (±0.27) 0.800 1.000
D PRP18: pre-mRNA processing factor 18 H82325 10p12.33 0.52↓ (±0.28) 0.086 0.265 0.97 (±0.22) 0.791 1.000
D TFDP1: transcription factor Dp-1 W33012 13q34 0.76↓ (±0.009) 0.858 0.898 0.99 (±0.26) 0.957 1.000
D EIF2B2: eukaryotic translation initiation factor 2B, 
subunit 2 (beta, 39 kD)
R86304 14q24.3 0.64↓ (±0.19) 0.018 0.261 1.05 (±0.25) 0.765 1.000
D ZNF161: zinc finger protein 161 AA232647 17q23.3 0.71↓ 
0.75↓
(±0.11) 
(±0.13)
0.339 0.445 0.94 
1.08
(±0.31) 
(±0.11)
0.608 1.000 
1.000
D ZNF24: zinc finger protein 24 (KOX 17) AA447098 18q12 0.73↓ (±0.07) 0.651 0.732 1.10 (±0.46) 0.712 1.000
D ZNF358: Zinc finger protein 358 H20045 19p13 0.64↓ (±0.09) 0.304 0.411 0.93 (±0.30) 0.621 1.000
D MRPL4: mitochondrial ribosomal protein L4 AA490981 19p13.2 0.66↓ (±0.13) 0.030 0.265 0.90 (±0.16) 0.503 1.000
D RPS5: ribosomal protein S5 AA456616 19q13.4 0.66↓ (±0.13) 0.030 0.265 0.90 (±0.16) 0.503 1.000
D EZF-2: endothelial zinc finger protein 2 R63318 19q13.43 0.58↓ (±0.22) 0.061 0.265 0.87 (±0.23) 0.374 1.000
D ID1: inhibitor of DNA binding 1, dominant negative 
helix-loop-helix protein
AA457158 20q11 0.74↓ (±0.18) 0.210 0.317 1.06 (±0.13) 0.807 1.000
D SF3A1 splicing factor 3a, subunit 1. 120 kD T72698 22q12.2 0.71↓ (±0.13) 0.510 0.609 1.11 (±0.36) 0.967 1.000
E CTNNBIP1: catenin, beta interacting protein 1 R78539 1p36.22 0.59↓ (±0.33) 0.205 0.313 1.23 (±0.91) 0.836 1.000
E CTNNB1: catenin (cadherin-associated protein), 
beta 1, 88 kDa
AA442092 3p21 0.65↓ (±0.06) 0.628 0.712 0.99 (±0.08) 0.948 1.000
E WNT5A: wingless-type MMTV integration site 
family, member 5A
W49672 3p21-p14 0.72↓ (±0.19) 0.307 0.414 1.07 (±0.16) 0.899 1.000
E TGFBR2: transforming growth factor, beta 
receptor II (70–80 kD)
AA487034 3p22 0.71↓ (±0.17) 0.450 0.555 1.06 (±0.14) 0.906 1.000
E SIAH2: seven in absentia homolog 2 (Drosophila) AA029041 3q25 0.65↓ (±0.13) 0.037 0.265 1.01 (±0.19) 0.948 1.000
E PIK3R1: phosphoinositide-3-kinase, regulatory 
subunit, polypeptide 1 (p85 alpha)
R54050 5q12-q13 0.61↓ (±0.11) 0.539 0.636 1.25 (±0.75) 0.832 1.000
Table 1: List of affected genes that had a significant change in their mRNA expression when TGFβ-differentiated T84 cells were compared to T84 cells grown solely in collagen I gel 
(= TGFβ-treated vs. control) and T84 cells differentiated by soluble factors secreted by mesenchymal cells were compared to T84 cells grown solely in collagen I gel 
(= IMR treated vs. control). (Continued)B
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E PDGFRB: platelet-derived growth factor receptor, 
beta polypeptide
R56211 5q31-32 1.01 (±0.29) 0.957 0.973 1.23↑ (±0.16) 0.390 1.000
E EGFR: epidermal growth factor receptor 
(erythroblastic leukemia viral (v-erb-b) oncogene 
homolog, avian)
R35665
W48713
7p12 0.47↓ 
0.75↓
(±0.04) 
(±0.13)
0.022 
0.444
0.265 
0.550
1.02 
1.09
(±0.63) 
(±0.10)
0.806 
0.693
1.000 
1.000
E IGF2: insulin-like growth factor 2 (somatomedin A) N54596 11p15.5 0.57↓ 
0.63↓
(±0.16) 
(±0.17)
0.241 
0.335
0.345 
0.441
0.92 
1.23
(±0.27) 
(±0.86)
0.565 
0.912
1.000 
1.000
E SIAH1: seven in absentia homolog 1 (Drosophila) AA447531 16q12 0.57↓ (±0.23) 0.055 0.265 0.97 (±0.55) 0.920 1.000
E NLK: nemo-like kinase R70769 17q11.2 0.55↓ (±0.24) 0.298 0.504 0.85 (±0.39) 0.499 1.000
E SMAD4: SMAD, mothers against DPP homolog 4 
(Drosophila)
AA456439 18q21.1 0.78↓ (±0.14) 0.186 0.296 1.00 (±0.23) 0.870 1.000
F CTSS: cathepsin S AA236164 1q21 0.53↓ (±0.04) 0.327 0.433 0.90 (±0.30) 0.580 1.000
F PSMA3: proteasome (prosome, macropain) 
subunit, alpha type, 3
AA465593 14q23 0.58↓ (±0.19 0.319 0.426 1.11 (±0.68) 0.700 1.000
F PSMB6: proteasome (prosome, macropain) 
subunit, beta type, 6
AA070997 17p13 0.76↓ (±0.16) 0.093 0.265 1.00 (±0.12) 0.972 1.000
F TGM2: transglutaminase 2 (C polypeptide, protein-
glutamine-gamma-glutamyltransferase)
R97066 20q12 0.62↓ (±0.30) 0.171 0.284 0.73 (±0.24) 0.182 1.000
H KRT19:keratin 19 AA464250 17q21.2 13.90 (±16.73) 0.390 0.496 19.95 (±12.99) 0.499 1.000
J LOC440582: similar to Peptidyl-prolyl cis-trans 
isomerase E (PPIase E) (Rotamase E) (Cyclophilin 
E) (Cyclophilin 33)
W17246 1p34.3 0.79↓ (±0.20) 0.290 0.397 1.11 (±0.14) 0.293 1.000
J RP4-622L5: hypothetical protein RP4-622L5 T85191 1p36.11-p34.2 0.69↓ (±0.13) 0.066 0.265 1.11 (±0.37) 0.673 1.000
JE S T T99671 2q36 0.66↓ (±0.18) 0.610 0.698 0.99 (±0.30) 0.770 1.000
J FLJ12057 N77990 3q21 0.71↓ (±0.10) 0.394 0.501 1.01 (±0.26) 0.840 1.000
J MGC2198 H81199 3q27-q28 0.57↓ (±0.25) 0.258 0.364 1.21 (±0.97) 0.727 1.000
JE S T R74480 50 . 6 5 ↓ (±0.09) 0.148 0.272 0.93 (±0.55) 0.458 1.000
J CCL28: chemokine (C-C motif) ligand 28 R38459 5p12 0.63↓ (±0.13) 0.288 0.395 1.06 (±0.41) 0.905 1.000
Table 1: List of affected genes that had a significant change in their mRNA expression when TGFβ-differentiated T84 cells were compared to T84 cells grown solely in collagen I gel 
(= TGFβ-treated vs. control) and T84 cells differentiated by soluble factors secreted by mesenchymal cells were compared to T84 cells grown solely in collagen I gel 
(= IMR treated vs. control). (Continued)B
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J FCHO2: FCH domain only 2 H93842 5q13 1.03 (±0.54) 0.859 0.900 1.48↑ (±0.44) 0.277 1.000
J Hypothetical gene supported by AK126569 N92035 5q23 0.52↓ (±0.20) 0.161 0.277 0.94 (±0.31) 0.577 1.000
J SMG1: PI-3-kinase-related kinase SMG-1 W32907 6p12.3 0.70↓ (±0.22) 0.207 0.315 1.36 (±0.55) 0.259 1.000
J cDNA DKFZp667D095 R26163 8p22 0.61↓ (±0.32) 0.118 0.265 1.10 (±0.59) 0.857 1.000
J DPYS: hypothetical protein PRO2949 N73761 8q22 3.29↓ (±1.73) 0.513 0.611 0.85 (±0.54) 0.566 1.000
J D12S2489E AA397819 12p13.2-p12.3 0.66↓ (±0.06) 0.011 0.227 0.92 (±0.19) 0.678 1.000
J ZNF629: Zinc finger protein 629 AA128587 16p11.1 0.55↓ (±0.15) 0.157 0.275 0.93 (±0.33) 0.533 1.000
J cDNA FLJ32121 fis, clone PEBLM1000083 T69477 16q22 0.57↓ (±0.18) 0.124 0.265 0.85 (±0.25) 0.698 1.000
J SFRS14: splicing factor, arginine/serine-rich 14 AA485539 19p12 0.70↓ (±0.17) 0.201 0.310 1.88 (±1.38) 0.995 1.000
J PNPLA4: patatin-like phospholipase domain 
containing 4
AA449678 Xp22.3 0.58↓ (±0.09) 0.387 0.495 0.94 (±0.33) 0.634 1.000
J LOC286467: hypothetical protein LOC286467 R95805 Xq26.1 2.85↑ (±1.02) 0.293 0.400 0.85↓ (±0.42) 0.530 1.000
Genes are sorted by functional classification. A: Cellular metabolism (GO:0044237), Metabolism (other than energy metabolism), B: Generation of precursor metabolites and energy GO:0006091), 
C: Nucleic acid binding (GO:0003676), D: Transcription regulator activity (GO:0030528), E: Signal transducer activity (GO:0004871), Signal transduction (GO:0007165) and Cell communication 
(GO:0007154), F: Cellular macromolecule metabolism (GO:0044260), H: Organelle organization and biogenesis (GO:0006996I), I: Transport (GO:0006810), J: Biological process unknown 
(GO:0000004), Upward arrow denotes up-regulated mRNA expression, downward arrow down-regulated mRNA expression, bold indicates genes that have significant alteration in gene expression. 
Ratio is mean value calculated from three separate microarray experiments; SD is the standard deviation between separate experiments. Statistic probability, p-value, was calculated by using t-test. 
FDR is the calculated Benjamin-Hochberg false discovery rate.
Table 1: List of affected genes that had a significant change in their mRNA expression when TGFβ-differentiated T84 cells were compared to T84 cells grown solely in collagen I gel 
(= TGFβ-treated vs. control) and T84 cells differentiated by soluble factors secreted by mesenchymal cells were compared to T84 cells grown solely in collagen I gel 
(= IMR treated vs. control). (Continued)B
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Table 2: List of the 46 genes evincing a significant change in their mRNA expression both in TGFβ-treated compared to cultures grown in collagen I gel and medium (= TGFβ-
treated vs. control) and IMR fibroblast soluble factor-differentiated cultures compared to cultures grown in collagen I gel and medium (= IMR-treated vs. control).
Gene 
ontology 
class
Gene name GenBank no chromosomal 
location
TGFβ-treated vs. control IMR-treated vs. control ANOVA
ratio SD p-value FDR ratio SD p-value FDR p-value
A CYP1B1:cytochrome P450, family 1, 
subfamily B, polypeptide 1
AA448157 2p21 0.66↓ (±0.26) 0.724 0.795 0.68↓ (±0.23) 0.716 1.000 0.669
A UMPS: uridine monophosphate 
synthetase (orotate phosphoribosyl 
transferase and orotidine-5'-
decarboxylase)
AA426227 3q13 0.65↓ (±0.56) 0.365 0.464 0.68↓ (±0.45) 0.270 1.000 0.173
A GM2A: GM2 ganglioside activator 
protein
AA453978 5q31.3-q33.1 0.36↓ (±0.26) 0.041 0.265 0.45↓ (±0.47) 0.292 1.000 0.279
A AMD1: S-adenosylmethionine 
decarboxylase 1
R82299 6q21-q22 0.59↓ (±0.28) 0.054 0.265 0.80↓ (±0.50) 0.410 1.000 0.420
A AHCY: S-adenosylhomocysteine 
hydrolase
AA485626 20cen-q13.1 0.65↓ (±0.23) 0.081 0.265 1.30↑ (±0.42) 0.210 1.000 0.347
A HMOX1: heme oxygenase (decycling) 1 T71757 22q12 3.75↑ (±2.58) 0.693 0.769 0.70↓ (±0.54) 0.491 1.000 0.456
A ALAS2: aminolevulinate, delta-, 
synthase 2 (sideroblastic/hypochromic 
anemia)
AA410346 Xp11.21 0.48↓ (±0.15) 0.010 0.225 0.80↓ (±0.41) 0.299 1.000 0.322
C HIST1H2AC: histone 1, H2ac AA453105 6p21.3 0.78↓ (±0.24) 0.369 0.477 0.78↓ (±0.28) 0.180 1.000 0.196
C CDK6: cyclin-dependent kinase 6 H73724 7q21-q22 2.57↑ (±1.34) 0.418 0.525 0.61↓ (±0.34) 0.442 1.000 0.524
C APC7: anaphase-promoting complex 
subunit 7
T67474 12q13.12 0.77↓ (±0.07) 0.141 0.269 0.80↓ (±0.13) 0.221 1.000 0.211
C LASS4: LAG1 longevity assurance 
homolog 4 (S. cerevisiae)
AA025779 19p13.2 0.62↓ (±0.29) 0.282 0.388 0.73↓ (±0.33) 0.339 1.000 0.268
D RLF: Rearranged L-myc fusion sequence R26070 1p32 0.54↓ (±0.27) 0.467 0.571 0.77↓ (±0.29) 0.540 1.000 0.437
D TCF7: transcription factor 7 (T-cell 
specific, HMG-box)
AA480071 5q31.1 0.76↓ (±0.49) 0.180 0.291 0.80↓ (±0.42) 0.297 1.000 0.258
D TCF8: transcription factor 8 (represses 
interleukin 2 expression)
R22087 10p11.2 0.62↓ (±0.38) 0.371 0.479 0.74↓ (±0.39) 0.392 1.000 0.286
D TCEA2: transcription elongation factor 
A (SII), 2
AA412500 20q13.33 0.61↓ (±0.36) 0.241 0.345 0.72↓ (±0.33) 0.161 1.000 0.157
E TIE1: tyrosine kinase with 
immunoglobulin-like and EGF-like 
domains 1
AA432062 1p34-p33 0.68↓ (±0.20) 0.084 0.265 0.72↓ (±0.13) 0.070 1.000 0.077
E GPA33: glycoprotein A33 
(transmembrane)
AA055862 1q24.1 0.72↓ (±0.10) 0.679 0.756 0.80↓ (±0.16) 0.752 1.000 0.703
E MAPKAPK2: mitogen-activated protein 
kinase-activated protein kinase 2
AA455056 1q32 0.61↓ (±0.10) 0.031 0.265 0.80↓ (±0.21) 0.385 1.000 0.488
E PDZD2: PDZ domain containing 2 AA405458 5p13.2 0.62↓ (±0.07) 0.049 0.265 0.83↓ (±0.12) 0.350 1.000 0.428
E PRL:prolactin AA133920 6p22.2-p21.3 0.66↓ (±0.31) 0.368 0.470 0.69↓ (±0.29) 0.375 1.000 0.357
E AKAP12:A kinase (PRKA) anchor 
protein (gravin) 12
AA478542 6q24-q25 0.75↓ (±0.41) 0.246 0.351 0.77↓ (±0.35) 0.256 1.000 0.287B
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) E STAM: signal transducing adaptor 
molecule (SH3 domain and ITAM motif) 
1
AA485996 10p14-p13 0.56↓ (±0.26) 0.186 0.297 0.82↓ (±0.16) 0.382 1.000 0.396
E CARP: cardiac ankyrin repeat protein, 
cytokine inducible nuclear protein C193
AA488072 10q23.31 0.77↓ (±0.16) 0.038 0.265 0.82↓ (±0.17) 0.073 1.000 0.080
E MS4A1: membrane-spanning 4-domains, 
subfamily A, member 1 (Fc fragment of 
IgE, high affinity I, receptor for; beta 
polypeptide
N91385 11q12-q13.1 1.24↑ (±0.66) 0.612 0.699 1.63↑ (±0.62) 0.323 1.000 0.302
E DRPLA: dentatorubral-pallidoluysian 
atrophy (atrophin-1)
H08642 12p13.31 0.65↓ (±0.42) 0.330 0.436 0.80↓ (±0.53) 0.364 1.000 0.256
E PRKCB1: protein kinase C, beta 1/cDNA 
DKFZp761J0720
AA479102 16p11.2 1.70↑ (±0.75) 0.392 0.499 0.69↓ (±0.19) 0.376 1.000 0.557
E FPR1: formyl peptide receptor 1 AA425249 19q13.4 0.44↓ (±0.25) 0.018 0.261 0.79↓ (±0.37) 0.371 1.000 0.436
E PLCG1: phospholipase C, gamma 1 
(formerly subtype 148)
R76365 20q12-q13.1 0.48↓ (±0.23) 0.050 0.265 0.81↓ (±0.48) 0.656 1.000 0.646
E ARHGAP8: Rho GTPase activating 
protein 8
R69153 22q13.31 0.61↓ (±0.09) 0.017 0.261 0.80↓ (±0.23) 0.307 1.000 0.334
F REN: renin AA455535 1q32 0.44↓ (±0.32) 0.133 0.269 0.88↓ (±0.62) 0.385 1.000 0.326
F PSMD2: proteasome (prosome, 
macropain) 26S subunit, non-ATPase, 2
AA455193 3q27.1 0.72↓ (±0.39) 0.341 0.448 0.73↓ (±0.50) 0.362 1.000 0.280
F SERPINB6: serine (or cysteine) 
proteinase inhibitor, clade B 
(ovalbumin), member 6
AA410517 6p25 0.72↓ (±0.13) 0.369 0.477 0.74↓ (±0.27) 0.254 1.000 0.193
F CRYAB: srystallin, alpha B AA504943 11q22.3-q23.1 0.50↓ (±0.08) 0.096 0.265 0.72↓ (±0.30) 0.219 1.000 0.199
F TGM2: transglutaminase 2 (C 
polypeptide. protein-glutamine-gamma-
glutamyltransferase)
R97066 20q12 0.62↓ (±0.30) 0.171 0.284 0.73↓ (±0.24) 0.182 1.000 0.151
G C5: somplement component 5 N73030 9q32-q34 0.74↓ (±0.09) 0.175 0.286 0.76↓ (±0.35) 0.206 1.000 0.122
H COL5A1: collagen, type V, alpha 1 R75635 9q35 0.64↓ (±0.04) 0.618 0.704 0.78↓ (±0.28) 0.783 1.000 0.744
H PNUTL2: peanut-like 2 (Drosophila), T64878 17q22-q23 0.81↓ (±0.15) 0.408 0.514 1.15↑ (±0.08) 0.505 1.000 0.520
H COL18A1: collagen, type XVIII, alpha 1 W07798 21q22.3 0.57↓ (±0.17) 0.164 0.279 0.84↓ (±0.22) 0.411 1.000 0.414
I ATP6V0B: ATPase, H+ transporting, 
lysosomal 21 kD, V0 subunit c"
AA480826 1p32.3 0.69↓ (±0.05) 0.213 0.320 0.84↓ (±0.26) 0.244 1.000 0.276
I BZAP45: basic leucine-zipper protein 
BZAP45
AA463591 2q33 0.46↓ (±0.25) 0.151 0.273 0.73↓ (±0.30) 0.259 1.000 0.226
I ATP6IP1: ATPase, H+ transporting, 
lysosomal interacting protein 1
AA488715 Xq28 0.44↓ (±0.32) 0.205 0.312 0.84↓ (±0.48) 0.391 1.000 0.315
JE S T R00591 4p16.1 3.20↑ (±1.50) 0.445 0.550 0.78↓ (±0.48) 0.455 1.000 0.572
J RIPX: rap2 interacting protein x R74171 4q21.1 0.62↓ (±0.20) 0.175 0.287 0.68↓ (±0.25) 0.251 1.000 0.222
JE S T H63361 12q24.31 3.50↑ (±2.03) 0.271 0.376 0.66↓ (±0.26) 0.520 1.000 0.632
J hypothetical protein BC017488 W93317 16q13 0.60↓ (±0.05) 0.006 0.192 0.80↓ (±0.24) 0.345 1.000 0.354
J PTOV1 prostate tumour over expressed 
gene 1
AA486332 19q13.33 0.63↓ (±0.08) 0.090 0.265 0.84↓ (±0.17) 0.618 1.000 0.581
J LOC286467: hypothetical protein 
LOC286467
R95805 Xq26.1 2.85↑ (±1.02) 0.293 0.400 0.85↓ (±0.42) 0.530 1.000 0.716
Genes are sorted by functional classification. A: Cellular metabolism (GO:0044237), Metabolism (other than energy metabolism), C: Nucleic acid binding (GO:0003676), D: Transcription regulator 
activity (GO:0030528), E: Signal transducer activity (GO:0004871), Signal transduction (GO:0007165) and Cell communication (GO:0007154), F: Cellular macromolecule metabolism (GO:0044260), 
G: Inflammatory response (GO:0006954), H: Organelle organization and biogenesis (GO:0006996I), I: Transport (GO:0006810), J: Biological process unknown (GO:0000004), Upward arrow denotes 
up-regulated mRNA expression, downward arrow down-regulated mRNA expression, bold indicates genes that have significant alteration in gene expression. Ratio is mean value calculated from 
three separate microarray experiments; SD is the standard deviation between separate experiments. Statistic probability (p-value) for TGFβ-treated vs. control and for IMR-treated vs. control, were 
calculated by using t-test. FDR is the calculated Benjamin-Hochberg false discovery rate. All three groups, TGFβ-treated, IMR-treated and control, were compared together with ANOVA.
Table 2: List of the 46 genes evincing a significant change in their mRNA expression both in TGFβ-treated compared to cultures grown in collagen I gel and medium (= TGFβ-
treated vs. control) and IMR fibroblast soluble factor-differentiated cultures compared to cultures grown in collagen I gel and medium (= IMR-treated vs. control). (Continued)B
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Table 3: List of genes spotted twice on the microarray filter which evinced a significant change in their mRNA expression in TGFβ-treated T84 cells compared to T84 cells grown 
solely in collagen I gel (= TGFβ-treated vs. control).
Gene ontology 
class
Gene name GenBank no chromosomal 
location
TGFβ-treated vs. control
ratio SD ratio SD
A FDPS: farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, 
dimethylallyltranstransferase, geranyltranstransferase)
T66907
T65907
1q22 0.29↓ (±0.24) 0.57↓ (±0.45)
A GRP58: glucose regulated protein, 58 kD, R33030 15q15 0.56↓ (±0.12) 0.60↓ (±0.16)
C BAP1: BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase) H09065 3p21.31-p21.2 0.72↓ (±0.19) 0.68↓ (±0.17)
D DRAP1: DR1-associated protein 1 AA421977
AA406285
11q13.3 0.53↓ (±0.22) 0.60↓ (±0.19)
D AEBP1: AE binding protein 1 AA490462
AA490684
7p13 0.48↓ (±0.34) 0.60↓ (±0.32)
D ZNF161: zinc finger protein 161 AA232647 17q23.3 0.71↓ (±0.13) 0.75↓ (±0.11)
E IGF2: insulin-like growth factor 2 (somatomedin A) N54596 11p15.5 0.57↓ (±0.16) 0.63↓ (±0.17)
E MAST1: microtubule associated serine/threonine kinase 1 AA479623 19p13.2 0.51↓ (±0.18) 0.59↓ (±0.48)
E EGFR: epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene 
homolog, avian)
R35665
W48713
7p12 0.47↓ (±0.04) 0.75↓ (±0.13)
E EPHA1: ephrin receptor EphA1 N90246 7q34 0.66↓ (±0.10) 0.63↓ (±0.07)
E RNTRE: related to the N terminus of tre AA281057
AA281137
10p13 0.78↓ (±0.25) 0.71↓ (±0.21)
E EFNB2: ephrin-B2 AA461424
AA461108
13q33 0.77↓ (±0.20) 0.79↓ (±0.06)
F UBE2N: ubiquitin-conjugating enzyme E2N (UBC13 homolog, yeast) AA490124 12q21.33 0.76↓ (±0.16) 0.79↓ (±0.17)
I ATP6V0A1: ATPase, H+ transporting, lysosomal V0 subunit a isoform 1 AA427472 17q21 0.65↓ (±0.02) 0.62↓ (±0.08)
Genes are sorted by functional classification. A: Cellular metabolism (GO:0044237), Metabolism (other than energy metabolism), C: Nucleic acid binding (GO:0003676), D: Transcription regulator 
activity (GO:0030528), E: Signal transducer activity (GO:0004871), Signal transduction (GO:0007165) and Cell communication (GO:0007154), F: Cellular macromolecule metabolism 
(GO:0044260), I: Transport (GO:0006810), Downward arrow indicates down-regulated mRNA expression, bold indicates genes that have significant alteration in gene expression. Ratio is mean 
value calculated from three separate microarray experiments; SD is the standard deviation between separate experiments.BMC Genomics 2006, 7:279 http://www.biomedcentral.com/1471-2164/7/279
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uble factors. Differentiation altered expression of 372
genes, and 47 of them were altered by both mediators.
A major trend seen in differentiated cultures was a dimin-
ishing expression of transcription factors, growth factors
and molecules regulated by them. Also the transcription
of genes attending to the mRNA processing, translation
and folding of proteins were decreased in TGFβ1-differen-
tiated epithelial cells. The decreased expression of the
above-mentioned factors and signaling molecules, such as
cathepsin S or MRLP, were similar in our three-dimen-
sional epithelial cell differentiation model to those
observed in spontaneously differentiating Caco-2 adeno-
carcinoma cells [8-10,18,20]. Also in the mouse cell lines,
the genes attending to proliferation and transcription reg-
ulation, for example c-myc, have been shown to decrease
during differentiation of epithelial cells [9,21,22]. In
other studies of epithelial differentiation, both in vivo [9]
and in vitro [10,18], the number of down-regulated genes
compared to up-regulated genes has not been so promi-
nent as in this study. However, it is noteworthy that in
these previous studies, as well as in our study, most func-
tional groups show particularly distinct down-regulation
of gene expression in differentiated cells.
There were several genes that are previously shown to be
affected in spontaneously differentiating Caco-2 cells, and
that had significant change transcription in our model:
The transcription of genes associated with proliferation
such as c-myc or cyclin D2 were decreased in TGFβ1-dif-
ferentiated cells and in differentiated Caco-2 cells
[8,10,18]. Also the genes coding proteins attending to the
gene expression, for example helicases and zinc finger
proteins, were down-regulated in TGFβ1- and IMR-differ-
entiated cells similarly as in differentiated Caco-2 cells
[18]. Transcription of genes associated to protein synthe-
sis, such as ribosomal proteins and translation initiators
(E2F4) [10], were decreased in TGFβ1- and IMR-differen-
tiated as in differentiated Caco-2 cells [10,18]. Decreased
expression of ubiquiting-conjugating enzymes was con-
sistent with the findings derived from differentiated Caco-
2 cells [10,18]. Ubiquitinated proteins then recognized by
26S proteasome complex and then destructed. From pro-
teasome complex proteins one component of 26S com-
plex (PSMD2) and two components of 20S complex
(PSMA3 and PSMB6) were down-regulated in TGFβ1-dif-
ferentiated cells. In differentiated Caco-2 cells Mariadason
et al. did not find alterations in 26S complex but they
found several components of 20S complex being down-
regulated [18]. In that study expression of several signal-
ing molecules in MAPK-pathway were decreased [18],
whereas in our study only the expression of MAPKAPK2
from MAPK-pathway was significantly decreased. Genes
that were commonly affected in TGFβ-, wnt- and receptor
tyrosine kinase-signaling routes are being discussed later
in the text.
In cell division and cellular growth there is an increase in
expression of genes regulating transcription, as well as
genes coding for mRNA splicing machinery, protein trans-
lation and protein folding machinery [22]. We saw an up-
regulation of genes that control protein synthesis such as
Table 4: Microarray data and LightCycler RT-PCR mRNA levels as ratios of VRK2, GM2A, CRYAB, TAGLN, DRPLA, DIO2, PSMB, 
ROK1, PLCG and KRT19.
Gene ontology 
class
name GenBank no microarray 
TGFβ-treated 
vs. control
RT-PCR TGFβ-
treated vs. control
microarray IMR-
treated vs. control
RT-PCR IMR-
treated vs. control
ratio SD ratio SD ratio SD ratio SD
A GM2A AA453978 0.43↓ (±0.26) 0.39↓ (±0.38) 0.75↓ (±0.47) 0.29↓ (±0.19)
AD I O 2 R 6 2 2 4 2 0.49↓ (±0.38) 0.01↓ (±0.02) 0.99 (±0.76) 1.12 (±1.6)
D ROK1 W73792 0.47↓ (±0.25) 0.32↓ (±0.13) 0.80 (±0.47) 1.34↑ (±0.23)
E DRPLA H08642 0.65↓ (±0.42) 0.71↓ (±0.12) 0.80↓ (±0.53) 0.66↓ (±0.24)
EP L C G 1 R 7 6 3 6 5 0.48↓ (±0.23) 0.33↓ (±0.26) 0.81↓ (±0.48) 0.47↓ (±0.28)
F VRK2 AA490617 0.89↓ (±0.16) 0.04↓ (±0.03) 0.78↓ (±0.22) 0.24↓ (±0.34)
F CRYAB AA504943 0.40↓ (±0.08) 0.71↓ (±0.30) 0.72↓ (±0.30) 0.62↓ (±0.13)
F PSMB AA070997 0.76↓ (±0.16) 0.30↓ (±0.15) 0.99 (±0.12) 0.51↓ (±0.24)
H KRT19 AA464250 13.90 (±16.73) 2.43↑ (±0.83) 19.95 (±12.99) 1.14 (±0.32)
TGFβ-differentiated T84 cells compared to T84 cells grown solely in collagen I gel (= TGFβ-treated vs. control) and T84 cells differentiated by 
soluble factors secreted by mesenchymal cells compared to T84 cells grown solely in collagen I gel (= IMR-treated vs. control). Genes are sorted by 
functional classification. A: Cellular metabolism (GO:0044237), Metabolism (other than energy metabolism), D: Transcription regulator activity 
(GO:0030528), E: Signal transducer activity (GO:0004871), Signal transduction (GO:0007165) and Cell communication (GO:0007154), F: Cellular 
macromolecule metabolism (GO:0044260), H: Organelle organization and biogenesis (GO:0006996I). Upward arrow denotes up-regulated mRNA 
expression, downward arrow down-regulated mRNA expression, bold indicates genes that have significant alteration in gene expression. Ratios are 
the mean values calculated from three separate microarray experiments and five separate RT-PCR experiments, the calculated standard deviations 
(SD) between separate experiments is in the brackets.BMC Genomics 2006, 7:279 http://www.biomedcentral.com/1471-2164/7/279
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ribosomal protein (RPS5), mitochondrial ribosomal pro-
tein (MRLP4), and initiation factor (EIF2B2) in undiffer-
entiated cells. Genes taking part to nuclear RNA
processing (PRP18) and splicing, (SFRS1 and SF3A1),
exhibited up-regulation in undifferentiated epithelial cells
compared to the differentiated cells. Also genes coding
ubiquiting-conjugating enzymes (UBE2N and UBE2I),
and two genes from proteasome complex (PSMA3 and
PSMB6), were up-regulated in undifferentiated epithelial
cells. Increased demand of energy in proliferating cells in
known to induce up-regulation of genes coding oxidative
phosphorylation machinery [22]. In our model genes
coding components of oxidative phosphorylation path-
way, (SDHB and UQCR), were up regulated in undifferen-
tiated cultures. All these above mentioned genes, were up-
regulated in dividing epithelial cells in the study of Stap-
penbeck et al. that was done with mouse small intestinal
epithelial progenitors [22]. Hence these changes in the
gene expression imply that epithelial cells grown
untreated in collagen I gel cultures were more actively
dividing than epithelial cells treated with TGFβ1 or with
IMR fibroblasts.
Genes involved in TGFβ-, wnt- and receptor tyrosine 
kinase-signaling routes (Fig. 3)
The transcription of the genes on TGFβ-, receptor tyrosine
kinase-(RTK), and wnt-pathways are known to be affected
upon differentiation of the epithelial cells [8-11,18,23].
As our epithelial cell differentiation model revealed a
number of both expected and new transcripts regulated by
TGFβ which might be involved in these pathways, all
results from microarrays were depicted in the form of sig-
naling cascades. The detailed signaling pathway picture
(Fig. 3) was drawn according to the Kyoto Encyclopedia of
Genes and Genomes (KEGG) [24] in homo sapiens [25]
and according to previously published results [2-4,26-37].
The focus was set to describe the cross-talk between sign-
aling pathways.
In our epithelial cell differentiation model TGFβ1
induced up-regulation of TGFβ co-repressor TGIF and
TGFβ early growth response gene (TIEG), and down-regu-
lation of type II TGFβ receptor (Tβ RII), CREB binding
protein (CREBBP), transcription factor Dp-1 (TFDP1),
E2F4/5, c-myc and Id1 (Fig. 3). In the intestine TGFβ
Densitometric analysis of Western blot experiments and microarrays of β-catenin, EGFR, c-myc, cytokeratin 19 protein and  mRNA Figure 1
Densitometric analysis of Western blot experiments and microarrays of β-catenin, EGFR, c-myc, cytokeratin 19 protein and 
mRNA. Proteins and mRNAs were extracted from undifferentiated control cell culture grown in collagen I and medium, or dif-
ferentiated cultures which were differentiated either by TGFβ1 or soluble factors secreted by IMR-90 cells. Results from the 
expression ratios from differentiated cell cultures were compared to undifferentiated control culture. The calculated values are 
from four β-catenin, five cytokeratin 19 two EGFR and two c-myc labeled Western immmunoblots. The EGFR, β-catenin, 
cytokeratin 1 and c-myc results were from three separate microarrays, EGFR having two separate probes on the filter. Bars 
indicate the standard deviation of separate experiments (Fig. 1A). Two representative Western blots subjected to densitomet-
ric analysis (Fig. 1B).
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receptors and ligands are expressed predominantly in the
differentiated compartment [1]. In Caco-2 cells the
expression of Tβ RII has been shown to spike during tran-
sition from proliferation to differentiation and then to
decline after transition [10]. In Caco-2 cells the induction
of TIEG transcription is used as an indicator of activation
of the TGFβ-signaling pathway by differentiation [10]. In
another study made with Caco-2 cells the transcription of
E2F5 and c-myc was shown to decrease upon differentia-
tion [18]. Comparing our results to others, it appeared
that the TGFβ pathway was active in our TGFβ-treated, dif-
ferentiated, cell culture [8,10,18,27].
We showed that TGFβ1 induced down-regulation of the
expression of β-catenin, SIAH, ICAT and TLE1. However,
E-cadherin remained constant and the expression of Tcf-4
was exiguous in the wnt pathway (Fig. 3). The wnt-signal-
ing pathway is known to abate in differentiated epithelial
cells in cultures [8,10,18] and in the intestine [9,20]. It
would thus appear that the wnt signaling pathway down
stream on β-catenin is quiescent in TGFβ-differentiated
cells [8-10,18,20].
Furthermore TGFβ1 decreased expression of the EGFR, the
p85 subunit of PI3-K, PLCγ, c-myc, GRB and NFκB (Fig.
3). In normal epithelial cells the activation of the RTK-
pathway, for example EGFR, is known to activate PI3-
kinase and PLCγ [33] and also to promote proliferation
and growth [33,38]. The decreased activation upstream of
the RTK-pathway might be a result of decreased expres-
sion of c-myc and decreased proliferation [33]. The
expression of the p85 subunit of PI3-K was decreased in
our TGFβ-differentiated T84 cells. In contrast to our
results, in differentiated Caco-2 cells the transcription of
PI3-K p85 has been found to be increased [10]. However,
the over-expression of PI3-K p85 subunit is shown to
inhibit differentiation and over-expression of p110 to
promote differentiation [39], suggesting that a balance
between different subunits is vitally important.
In the present study TGFβ1-induced differentiation
appeared to alter the expression of the signaling mole-
cules upstream on the RTK- and wnt-pathways. We there-
fore directed our attention to the mechanisms underlying
the reprogramming events taking place during epithelial
Immunostainings of cell clusters in the three-dimensional intestinal epithelial cell differentiation model Figure 2
Immunostainings of cell clusters in the three-dimensional intestinal epithelial cell differentiation model. The nuclei in undifferen-
tiated T84 epithelial cell clusters were more intensively labeled with c-myc antibody (Fig. 2A) than nuclei in TGFβ-treated cell 
clusters (Fig. 2B). The staining intensity with cytokeratin 19 was lower in undifferentiated T84 epithelial cell clusters (Fig. 2C) 
than in TGFβ-treated cell clusters, especially seen in the apical part of the epithelial cells in the lumen of organized cell cultures 
(Fig. 2D). Scale bar = 20 μm.
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cell differentiation. In order to understand the mecha-
nisms underlying the differentiation of epithelial cells it is
essential to understand precisely how the signals are mod-
ulated and fine-tuned within the cells. During the differ-
entiation of epithelial cells several signaling pathways are
known to act synergistically and to interact via common
mediators, modulate the outcomes by varying the inter-
acting partners [28,29,31,33,35,36], or co-operatively
fine-tune the transcription of a single molecule
[2,23,27,32-34,40]. For example Akt, a serine/threonine
kinase, is a molecular nodal point of several signaling cas-
cades [36] which can deliver the signal to several different
pathways and alter the outcome of the signal as well: In
the wnt-pathway Akt activates proliferation by preventing
the formation of the GSK3β/APC/β-catenin-destruction
complex [33], in the NFκB route it regulates antiapoptosis
[35], and by positively regulating CREBBP it also regulates
differentiation [36]. In our three-dimensional epithelial
cell differentiation model in TGFβ1-treated cells Akt2 was
down-regulated (Fig. 3). Thus the decreased expression of
Akt may induce the down-regulation of the wnt and
NFκB-route and decreased signaling to CREBBP. Indeed
all these signaling routes (Fig. 3.) were down-regulated in
TGFβ1-treated culture. Several signaling pathways can
synergistically modulate the function of a single gene such
as c-myc, whose expression is tightly regulated by the
TGFβ-, wnt- and RTK-pathways. Activation of the TGFβ
route reduces expression of c-myc [27] contribute to
growth arrest [32], whereas activation of the wnt and RTK-
pathways induces c-myc expression and proliferation
Schematic illustration of mRNA expression levels in TGFβ-treated T84 epithelial cells compared to control cell culture Figure 3
Schematic illustration of mRNA expression levels in TGFβ-treated T84 epithelial cells compared to control cell culture. Results 
are from three separate experiments. In TGFβ-treated cells the expressions of EGFR, PI3K, c-myc and GRB in the Receptor 
tyrosine kinase (RTK) pathway were decreased. In the TGFβ signaling pathway the expression of TFDP1 and E2F4/5 were 
decreased, TGIF increased and c-myc as well as IDs decreased. In the TGFβ-treated cells transcription of β-catenin was 
decreased in the wnt signaling pathway, the wnt+-route was down-regulated, as indicated by down-regulation of c-myc and 
cyclin D2. The red indicates up-regulation in mRNA expression in a gene with high expression level; pink indicates up-regula-
tion in gene with a low expression level. Dark green indicates a significant down-regulation in a gene which has high expression 
level; light green indicates down-regulation in a gene with low expression level; dark grey indicates a high level of expression 
with no change, light grey no change with low concentration expression. White indicates absence from the filter.
TGFb
RIII
PM
upregulated,  high intens.
not on  the  filter
no  change,  low intens
no  change,  high intens.
downregulated,  low intens.
downregulated,  high intens.
upregulated,  low intens.
nuclear membrane
Idax
DVL2
DVL2
Axam
-Catenin -Catenin
wnt+
LEF1
TCF7L TCF7
-Catenin
ICAT
Duplin
Xsox
NLK
DNA
P+
-Catenin -P
CUL1 Rbx1 Skp1
TrCP
latent
active
TG2
RII RIII RI
SARA
SMAD2/3
SMAD4
SMAD  binds LEF/TCF
SMAD  binds
LEF/TCF+
negative
regulation of
diferentiation
proliferation
degradation
Axin
+A
CRI1
c-myc Cyc D2 Cyc D1
LEF1
TCF7L TCF7
-Catenin
differentiation
p15
DNA
CREBBP
SMAD2/3 SMAD4
c-myc
DNA
E2F4/5 TFDP1 p107
SMAD2/3 SMAD4
-Catenin
SIAH
TLE1 APC
SIP Skp1
+u
ID1
SMAD7
SMAD2/3 CUL1
Rbx1n
Skp1 +u
SMAD
degradation
TGF   signalling pathway
FZD4 FZD6 FRZB
WNT4 WNT2 WNT5A
LRP6 DKK3
wnt  signalling pathway
TGFb
RIII
FGF2
FGF1
EGFR
IGF2
IGF1
IGFR1 IGFR2 FGFR2 FGFR1 FGFR4
HGF
EPR
EGF
antiapoptosis
DNA
proliferation
TGIF
SMAD2/3 SMAD4
?
DNA
PTEN
PI3K
PIP3
RRAS2
GRB2
GRB10
SOS1
SOS2
RAF1
MEK
MAPK1
MAPK1
DAG
c-myc
proliferation
apoptosis
PDGFR
PDGF
PDGF
Akt1
Akt2
RIII
upregulated,  high intens.
not filter
no  change,  low intens
no  change,  high intens.
downregulated,  low intens.
downregulated,  high intens.
upregulated,  low intens.
,  .
, 
,  intens.
,  .
,  .
,  .
nuclear membrane
GSK3β
DVL2
DVL2
Axam
DVL2
DVL2
DVL2
DVL2
DVL2
DVL2
β    -Catenin
-Catenin
wnt
-Catenin
wnt+
LEF1
TCF7L TCF7
-Catenin
ICAT
-Catenin
LEF1
TCF7L TCF7
-Catenin
LEF1
TCF7L TCF7
LEF1
TCF7L TCF7 TCF7L TCF7
ICAT ICAT
NLK NLK
-Catenin -P
CUL1 Rbx1 Skp1
TrCP
-Catenin -P
CUL1 Skp1 CUL1 Skp1
TrCP
latent
active
TG2
latent
active
TG2
latent
TGFβ active
TGFβ
TG2
RII RIII RI
TGFβ
RII
TGFβ
RIII
TGFβ
RI
SARA SARA
SMAD2/3
SMAD4
SMAD2/3
SMAD4
SMAD  binds LEF/TCF
SMAD  binds
LEF/TCF+
β   -Catenin
negative
regulation of
diferentiation
proliferation
β-catenin
degradation
Axin Axin
+A +A
CRI1 CRI1
c-myc Cyc D2 Cyc D1 c-myc Cyc D2 Cyc D1
LEF1
TCF7L TCF7
-Catenin
LEF1
TCF7L TCF7 TCF7L TCF7
-Catenin
differentiation
CREBBP
SMAD4 SMAD4
c-myc
E2F4/5 TFDP1 p107
SMAD4
c-myc
E2F4/5 TFDP1 p107
SMAD4
E2F4/5 TFDP1 p107
SMAD4 SMAD4
-Catenin
SIAH
TLE1 APC
SIP Skp1
SIAH
TLE1 APC
SIP Skp1
SIAH
TLE1 APC
SIP Skp1
TLE1 APC
SIP Skp1
+u
ID1
SMAD7 SMAD7
SMAD2/3 CUL1
n
+u
CUL1
n
+u
SMAD
degradation
β
FZD4 FZD6 FRZB
WNT4 WNT2 WNT5A
LRP6 DKK3 FZD4 FZD6 FRZB
WNT4 WNT2 WNT5A WNT4 WNT2 WNT5A
LRP6 DKK3
RIII
FGF2
FGF1
FGF2
FGF1
EGFR
IGF2
IGF1
IGFR1 IGFR2
IGF2
IGF1
IGF2
IGF1
IGFR1 IGFR2 FGFR2 FGFR1 FGFR4 FGFR2 FGFR1FGFR2 FGFR1 FGFR4
HGF HGF
antiapoptosis
proliferation
TGIF
SMAD2/3 SMAD4
?
DNA
TGIF
SMAD2/3 SMAD4
TGIF
SMAD2/3 SMAD4 SMAD2/3 SMAD4
DNA
PTEN PTEN
PI3K
PIP3
RRAS2
GRB2
GRB10
GRB2
GRB10
SOS1
SOS2
SOS1
SOS2
RAF1
MAPK1
MAPK1
MAPK1
MAPK1
PLCγ    
IκB
NFκB
DAG
PKCα
c-myc
proliferation
apoptosis
PDGFR
PDGF
PDGF
PDGF
PDGF
Akt1
Akt2
Akt1
Akt2
RTK pathway
β    -Catenin β    -Catenin
β    -Catenin β    -Catenin
β    -CateninBMC Genomics 2006, 7:279 http://www.biomedcentral.com/1471-2164/7/279
Page 15 of 20
(page number not for citation purposes)
[23,33,40]. C-myc has been shown to be down-regulated
upon differentiation in epithelial cell cultures [8,10,18]
and in the normal intestine [9,40]. In our crypt villus axis
model we saw down-regulation of c-myc at both mRNA
and protein levels in differentiated cells, suggesting the
synergistic action of these signaling routes to the expres-
sion of c-myc (Fig. 3). It appears that the molecular
changes seen in RTK- and wnt-signaling pathways are con-
sequences of TGFβ1. Our results suggest that TGFβ1 mod-
ulates, either directly or indirectly, the transcription of the
mediators on these signaling pathways (Fig. 3).
T84 cells have been reported to respond correctly to added
stimulants in the TGFβ- and RTK-pathways, and the wnt-
pathway at β-catenin level [12,13,41-43]. As all cancerous
cell lines are known to have mutations in their genes [44],
the molecules under investigation might also have been
mutated [43] and this must be borne in mind when inter-
preting results.
Differentially expressed novel, as yet uncharacterized 
genes
Altogether 26.5% of the differentially expressed genes
detected here had hitherto no characterized functions.
Several of them for example LOC440582, RP4-622L5,
FLJ12057, FCHO2, SMG1 and several ESTs (Table 1.) are
reported to be expressed at the embryonic stage but not in
juveniles. Furthermore they have been shown to be
expressed in the intestine [51]. These sequences with
unknown function are especially interesting in the search
for new players which may act in epithelial cell differenti-
ation.
TGFβ-induced versus IMR fibroblast-induced 
differentiation
The comparison of results from TGFβ1- and IMR-differen-
tiated cultures revealed 47 commonly altered genes.
Majority of them [39] were similarly expressed, down-reg-
ulated. It is known that mesenchymal cells secrete several
soluble factors which control epithelial growth, motility
and morphogenesis [6]. IMR fibroblasts, by secreting sev-
eral mediating factors, induce natural differentiation
[1,45]. The IMR fibroblast-induced differentiation of T84
cells has been shown to occur in a TGFβ1-dependent
manner [12]. However, after seven days of culturing a
smaller proportion of cells is differentiated in IMR-differ-
entiated than in TGFβ1-differentiated culture [12]. Also in
the present study, the expression changes detected by
microarray were stronger in the TGFβ1-differentiated
cells, compared to IMR-differentiated cells. In Caco-2 cells
the expression of platelet-derived growth factor receptor
(PDGFR) has been shown to spike during transition from
proliferation to differentiation and to decline after the
transition [10]. In our model the transcription of PDGFR
was up-regulated in IMR- but unchanged in TGFβ-differ-
entiated cells (Table 4). Comparing our results to the ones
from Caco-2 cells, it looks as IMR-differentiated cells may
have been in transition from proliferation to differentia-
tion and TGFβ1-differentiated cell cultures had already
passed the transition stage. According to the mRNA
expression data, the TGFβ1-induced differentiation
appears to be more potent than the natural IMR fibrob-
last-induced differentiation. This might reflect the fact
that TGFβ1 is a single, potent differentiating factor always
inducing similar differentiation, whereas the IMR fibrob-
lasts secrete various factors which may induce variation
also in differentiation.
Conclusion
Our results suggest that TGFβ1 modulates mediators on
wnt- and receptor tyrosine kinase-pathways. By compar-
ing mRNA expression patterns from TGFβ1-differentiated
epithelial cells and mesenchymal cell soluble factor differ-
entiated epithelial cells the differentiation induced by
TGFβ1 might be more potent than the differentiation
induced by mesenchymal cells. This study indicates that
this three-dimensional epithelial cell differentiation is a
suitable tool in studying regulatory mechanisms during
differentiation in intestine. In conclusion the present
results would indicate that our model is a good tool for
finding new players acting in the differentiation of epithe-
lial cells.
Methods
Sample material
Cell lines and cell cultures
Human intestinal epithelial T84 cells (CCL 2'48, ATCC
Rockville, MD, USA) were cultured in three-dimensional
type I collagen gel as previously described [12]. T84 cells
were induced to differentiate either by adding 20 ng/ml
human recombinant TGFβ1 (hTGF-β1, R&D Systems
Europe, Oxon, UK) or by soluble factors secreted by IMR-
90 type human embryonic lung fibroblasts (CCL 186,
ATCC). IMR fibroblasts, cultured on the top of the epithe-
lial cells, were separated from the epithelial cells by cell-
free collagen layer. T84 cells cultured within collagen gel
supplemented with medium were used as undifferenti-
ated control. We studied only undifferentiated and differ-
entiated epithelial cells harvested after seven days of
culturing. All experiments were carried out in triplicate.
Isolation of RNA
The mRNA was extracted from the cell culture samples to
ice-cold TRIzol reagent (Life Technologies, Inc. Frederick,
MD, USA) according to the manufacturer's protocol. All
samples were subjected to DNAse I treatment (Roche
Diagnostics GmbH, Mannheim, Germany). Purity and
quantity of total RNA was determined by spectrophotom-
etry (Bio Rad, Sweden) and quality was checked by agar-
ose gel electrophoresis. The amount of rat tail collagenBMC Genomics 2006, 7:279 http://www.biomedcentral.com/1471-2164/7/279
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was same both in undifferentiated and differentiated cul-
tures, therefore potential rat RNA contamination would
not produce a problem in microarray analysis.
cDNA synthesis and array hybridization
Gene expression was monitored using a Human GeneFil-
ter GF200 (Research Genetics, Huntsville, AL, USA), con-
sisting of 5188 test sequences, 96 control points and 192
housekeeping genes. Arrayed sequences contained both
genes with known or predicted function and expressed
sequence tags (ESTs) with unknown function. Probe prep-
aration and microarray hybridization were performed fol-
lowing manufacturer's (Research Genetics, Huntsville, AL,
USA) protocol using 1.5 μg total RNA as template, 10 μl
(10 mCi/ml) 33P dCTP (ICN Radiochemicals), 1,5 μl
dNTP mix containing dATP, dTTP, dGTP at 20 mM
(Finnzymes, Finland), 1,5 μl reverse transcriptase (Life
Technologies, Inc. Frederick, MD, USA), 1,0 μl DTT (Life
Technologies, Inc. Frederick, MD, USA). 33P-labeled
cDNAs were synthesized for 90 min at 37°C. 33P-cDNA
products were separated from unincorporated nucleotides
by chromatography on Bio-Spin 6 (Bio-Rad, Sweden). Fil-
ter was prehybridized with human 5 μg Cot-1 (Life Tech-
nologies, Inc. Frederick, MD, USA) DNA and 5 μg poly dA
(Research Genetics, Huntsville, AL, USA) in MicroHyb
solution (Research Genetics, Huntsville, AL, USA) to min-
imize non-specific labeling. The denatured 33P-cDNA was
added and incubated for 12 h at 42°C in roller bottle. The
arrays were washed at high stringency (twice in 2 × SSC
1%SDS, and 0.5 × SSC) and signals were detected from
storage phosphor screens by Storm 860 phosphoimager
(Molecular Dynamics, Amersham Biosciences, Bucking-
hamshire, England) with 50-micron resolution as previ-
ously described [46]. The label was removed from filter by
boiling in 0.5% SDS. The efficiency of the removal was
ensured with storage phosphor screens by Storm 860
phosphoimager after exposing for 12 h. The undifferenti-
ated, TGFβ1-differentiated and IMR-differentiated sam-
ples were hybridized on same filter. All the experiments
were done in triplicate.
Processing and statistical analysis of the microarray data
Filter images were aligned and spot intensities analyzed
with Pathways Software (Research Genetics). The han-
dling of the raw data, normalization and improvement of
fidelity by setting a cut-off value were done as previously
described in Juuti-Uusitalo and associates [46]. Intensity
values were normalized in order to avoid possible differ-
ences in the amounts of RNA and differences in hybridi-
zation efficiency. The normalization factor was
determined before background subtraction. The back-
ground intensity was determined by the Pathways Soft-
ware (Research Genetics). The normalization was done by
the sum method [47]. The scaling factor was set to ensure
that the sums of spot intensities were equal for all filters.
The scatter plots for the normalized data are shown as the
Additional data (see Additional file 1 and Additional file
2).
Prior to statistical analyses the data normalized by the
sum method was further normalized using a linear mixed
model. Normalizing data using a mixed model effectively
removes possible filter effects from the data. Mixed mod-
els contain both fixed effects that were manipulated dur-
ing the study and random effects that were not or could
not be manipulated during the study. In the current set-
ting, the best performing models treated cell lines and fil-
ters as fixed effects, and the hybridization order on every
filter as a random effect. Models with and without interac-
tion between fixed and random effects were compared
using analysis of variance, and were found not to differ
significantly. Therefore, models without interaction terms
were fitted. A separate model was fit for every gene. Resid-
uals from the models were approximately normally dis-
tributed and were used for statistical analyses. Two
population t-test was used for comparing gene expression
of differentiated cells to undifferentiated. The t-test p-val-
ues and Benjamin-Hochberg false discovery rates (FDR)
are shown in Tables 1 and 2. The linear mixed modeling
and statistical analyses were performed using R software,
version 2.3.1., and its library nlme version 3.1–73.
Approximately 11% of the genes were below the average
background intensity. Mills and Gordon by using oligo-
nucleotide arrays, have demonstrated that false positive
values were more frequent at the lowest level of expres-
sion [48]. Therefore, in order to improve fidelity, the low
intensity genes, 85% of all genes, were removed by setting
a cut-off value. Only genes with a low spot intensity value
in both of the compared pairs were removed.
According to Lee and Whitmore [49] three replicates are
necessary to obtain consistent and reliable findings in
cDNA microarray. Therefore we had three replicates, and
genes that had the change to same direction in all three
replicates we would get the result that is true for the whole
experimental group.
In order to eliminate the variation arising from the culture
conditions such as passage number and collagen support,
only those samples cultured, treated and extracted at the
same time and hybridized on the same filter were com-
pared with each other. Furthermore, only those genes
evincing the change in the same direction in all sample
pairs within a sample group and the mean ratio which was
above 1.25 were considered significant. 372 genes or ESTs
fulfilled these criteria and their mRNA expression was
considered to be significantly altered. As we took for anal-
ysis only those genes that were altered in all sample pairsBMC Genomics 2006, 7:279 http://www.biomedcentral.com/1471-2164/7/279
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within a sample group, we aimed to focus to the genes
actually altered in the whole sample group.
Clustering of genes was done with software programs
Cluster and Treeview and R 2.3.1 (package gregmisc ver-
sion 2.0.8). Prior to hierarchical clustering data was log2
transformed and expression values on all chips were trans-
lated to the same mean (0). Also, the residuals from
mixed models were clustered to check that the filter spe-
cific effect was removed. Spearman rank correlation coef-
ficient was used for calculation of distances between genes
or experiments. The hierarchical clustering tree was
inferred from the distances using average linkage method.
Cluster analysis for unfiltered data is presented as addi-
tional file (see Additional file 3) and the cluster analysis
for the residuals from mixed models is presented as addi-
tional file (see Additional file 4). This data shown that, as
anticipated, the filter specific effect can be removed and
the comparisons of the expression values effectively per-
formed.
The genes were grouped manually into ontology classes
according their known or predicted functions defined in
Gene Ontology Consortium [50]: Genes were sorted by
functional classification. A: Cellular metabolism
(GO:0044237), Metabolism (other than energy metabo-
lism), B: Generation of precursor metabolites and energy
GO:0006091), C: Nucleic acid binding (GO:0003676), D:
Transcription regulator activity (GO:0030528), E: Signal
transducer activity (GO:0004871), Signal transduction
(GO:0007165) and Cell communication (GO:0007154),
F: Cellular macromolecule metabolism (GO:0044260),
G: Inflammatory response (GO:0006954), H: Organelle
organization and biogenesis (GO:0006996I), I: Transport
(GO:0006810), J: Biological process unknown
(GO:0000004). The sequences on the arrays were not
annotated by Research Genetics, as the filter was released
in 1996. Therefore the annotation for the significantly
altered genes was done as follows: Sequence was sought
with the UniGene code given by Research Genetics from
Entrez UniGene [51] site that had the direct link to NCBI
Entrez Gene [52] that contains information about
genomic annotation and information about ontologies.
In this study annotations were done according to the
NCBI Entrez Gene [52]. The ontologies on that site were
supplied by EMBL-EBI GOA [53].
Genes which were arrayed twice on the GF200 filter func-
tioned as internal control points. The microarray experi-
ments and data included in this manuscript are available
in Gene Expression Omnibus repository at National
Center for Biotechnology Information [54] as Accession
GSE5170.
Real-time RT-PCR
Confirmation of microarray results was made with real-
time quantitative reverse transcription PCR (RT-PCR) as
previously described [46]. Primers were designed with the
assistance of the Primer 3 program [55] and were chosen
according to the requirements previously presented [46].
Genes for confirmation were selected from different func-
tional classes. The intensity values of the validated genes
varied from high (PSMB), to average (PLC6, EGFR and β-
catenin), below average (GM2A, CRYAB and DRPLA) to
intensity values just above the cut off threshold (DIO2,
ROK1) and below the cut off threshold (KRT19). The
probe sequences for primers and their functional classes
are set out in Table 5. PCR reactions were carried out in
the LightCycler apparatus using the LightCycler-FastStart
DNA Master SYBR Green I Kit (Roche Diagnostics GmbH)
as previously described [46]. The expression levels of
VRK2, GM2A, CRYAB, DRPLA, DIO2, PSMB, ROK1,
PLCG1 and KRT19 were measured by quantitative PCR
and were normalized by the expression values of house-
keeping gene GAPDH. After PCR, every sample was also
run in 1.5% agarose gel electrophoresis to ensure that a
product of correct size was amplified in the reaction.
Protein extraction and Western blotting
For Western immunoblotting proteins from the three-
dimensional cell culture were extracted directly to Lae-
mmli buffer [56]. Epithelial cells in the three-dimensional
cell culture were grown within collagen I gel, thus contain-
ing an excessive amount collagen protein. Loading to the
gel was therefore done by approximating the number of
cells in cultures. All samples were denatured and run in
Tris-Glycine Precast Gels (Invitrogen, Carlsbad, CA, USA).
Proteins were blotted according to the manufacturer's pro-
tocol (Invitrogen) to the nitrocellulose filter (Hybond C-
Extra, Amersham Biosciences, Ltd.). Polyclonal antibodies
against epidermal growth factor receptor (EGFR), cytoker-
atin 19 and c-myc (Santa Cruz Biotechnology, Inc. CA,
USA.) and β-catenin (BD Transduction Laboratories, CA,
USA) and a monoclonal antibody against β-actin (Sigma-
Aldrich, Saint Louis, MO, USA) were used for immunob-
lotting. The secondary antibody anti goat-HRP-conjugate
(DAKO, Glostrup, Denmark) was for detecting EGFR, anti
rabbit-HRP-conjugate (DAKO) for c-myc, anti-mouse-
HRP-conjugate (DAKO) for β-catenin, cytokeratin 19 and
β-actin. The nitrocellulose filter was incubated in EGFR or
c-myc primary antibody dilution and a comparable sec-
ondary antibody dilution, and then in ECL Plus Western
Blotting Detection Reagent (Amersham Biosciences Ltd.),
and finally exposed on Hyperfilm (Amersham Bio-
sciences, Ltd.) according to the ECL Plus Western Blotting
Detection Reagent (Amersham Biosciences, Ltd.) proto-
col. Primary and secondary antibodies were removed
from the filter according to manufacturer's protocol. The
filters were then re-probed with other primary antibodiesBMC Genomics 2006, 7:279 http://www.biomedcentral.com/1471-2164/7/279
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and processed as described above. The relative amounts of
β-catenin, cytokeratin 19, EGFR and c-myc were calcu-
lated from scanned images (grey-scale, 1200 dpi, TIF)
with Amersham Image Quant TL (Amersham Biosciences,
Ltd.). The calculated values are from four β-catenin, five
cytokeratin 19, two EGFR and two c-myc labeled Western
blots.
Immunohistochemical studies
In order to verify immunoblotting results TGFβ-differenti-
ated cultures, IMR-differentiated and control cultures
immunostained with cytokeratin 19 and c-myc antibodies
(Santa Cruz Biotechnology, Inc.) as previously described
[14]. The protocol in detail: After one week of culturing,
the cells were washed twice in PBS. They were fixed with
10% formalin over night at room temperature. Cell cul-
tures were processed in Shandon Citadel 1000 (Thermo
electron corporation, MA, USA) tissue processor where
they were dehydrated once for 15 min in 70% ethanol,
once for 15 min in 96% ethanol, three times for 15 min in
100% ethanol, three times for 15 min in xylene) and par-
affined twice for 30 min in melted paraffin. Finally the
samples were embedded to the paraffin blocks. 5 μm sec-
tions were cut from paraffin blocks. After the deparaffina-
tion of tissue sections three times for 10 min in xylene,
hydration (three times for 5 min in 99% ethanol, three
times for 3 min in 94% ethanol, once for 5 min in PBS)
then the antigen retrieval was performed by boiling slides
for 10 min in 0.01 M citrate buffer (pH 6.0), followed by
cooling to room temperature. Three washes in PBS (5 min
each) and blocking of the non-specific binding sites in
normal horse serum for 1 h at room temperature. Sections
were subsequently incubated overnight at +4°C with
either cytokeratin 19 or c-myc the primary antibody. After
overnight incubation at +4°C sections were washed three
times for 5 min in PBS, incubated in secondary antibody
for 30 min at room temperature, and the washed twice for
5 min in PBS. Endogenic peroxidase activity was removed
with 0.3% H2O2, for 1 h at room temperature. ABC-reac-
tion was done with the Vectabond TM reagent (Vector
Laboratories, Inc. Burlingame, CA, USA) 30 min at room
temperature. Sections were washed twice for 5 min in PBS.
The peroxidase reaction was performed for 5 min at room
temperature using DAB (DacoCytomation Inc. CA, USA)
as precipitate forming substrate. Finally the sections were
washed washed with tap water, dehydrated and mounted
to Mountquick (Daido Sangyo Co. Ltd, Tokyo, Japan).
Sections were left without counterstain to highlight the
labeling pattern. Sections not incubated with primary
antibodies served as negative controls.
Authors' contributions
K.J-U conducted all experimental procedures including
array experiments, data mining, and selected genes of
interest, verified results with quantitative RT-PCR, did
immunoblotting, immunohistochemical staining and
drafted the manuscript. K.K participated in study coordi-
nation, drafted the manuscript and edited visual appear-
ance. M.M. created the original study design, drafted the
manuscript and edited visual appearance. J.T carried out
the statistical analysis and drafted the manuscript. H.K.
participated in study design and drafted the manuscript.
All authors read and approved the final manuscript.
Table 5: List of used primers, their temperature and MgCl optimum and length of product.
name direction sequence size MgCl μmol annealing temp
GAPDH F ATG CCA GTG AGC TTC CCG TTC AGC 199 2 70
GAPDH R TGG TAT CGT GGA AGG ACT CAT GAC
VRK2 F GCAGAAAGAGGAGAAACTGATTGGA 245 4 62
VRK2 R CCGTGCTGACTGTGGAAGTGTATT
GM2A F TTCCTTGCCACTGTCCCTTCA 222 3 61
GM2A R CTTCCTCACACCGCTCCATTCT
CRYAB F CCCCTTCTTTCCTTTCCACTCC 266 3 62
CRYAB R CACCTCAATCACATCTCCCAACAC
DRPLA F GAACTCTCCCTAACCCCCTGCTT 279 3 63
DRPLA R GTGGCTTGTCGCTTTCCTTCTTC
DIO2 F GGGCATCCTCAGCGTAGACTTG 295 4 64
DIO2 R GCCACTGTTGTCACCTCCTTCTGT
PSMB F TATTTATTGTTGTGGTGCTGGGACA 350 4 65
PSMB R TCTTGGCTTCCTCCTCCTCCA
ROK1 F CCTGTTCTTGTTTTTGTTCAGTCCA 298 3 61
ROK1 R TTGCTTTTCCCTTATTCCCTGCTC
PLCG1 F CTCAACTTCCAGACCCCTGACAA 237 3 64
PLCG1 R CACCTCAATCTCCACAAAAGGACAC
KRT19 F GCACCCTTCAGGGTCTTGAGAT 346 3 64
KRT19 R AAGACACCCTCCAAAGGACAGCBMC Genomics 2006, 7:279 http://www.biomedcentral.com/1471-2164/7/279
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